Leaflet AXHIDROX 2.2mg / dose cream

Indicated for: chronic obstructive pulmonary disease

Route of administration: cutaneous

Substance: glycopyrronium bromide (bronchodilator)

ATC: D11AA01 (Dermatologicals | Other dermatological preparations | Antihidrotics)

Precautions:
Glaucoma warning
Glaucoma warning

Use caution if you have glaucoma or increased eye pressure.

Anticholinergic effects
Anticholinergic effects

May cause dry mouth, constipation, urinary retention, or blurred vision.

Elderly warning
Elderly warning

Older people may have an increased risk of side effects.

Glycopyrronium bromide is an anticholinergic medication primarily used for the treatment of obstructive respiratory diseases, such as chronic obstructive pulmonary disease (COPD). It works by blocking muscarinic receptors in the airways, leading to relaxation of bronchial smooth muscles and airway dilation, making breathing easier.

It is indicated for:

- Maintenance treatment of COPD to relieve symptoms such as shortness of breath.
- Reducing the frequency of disease exacerbations.

Glycopyrronium bromide is administered via an inhaler, usually once daily, as directed by a doctor.

Side effects may include dry mouth, throat irritation, cough, constipation, headache, or, rarely, allergic reactions. It is contraindicated in patients with hypersensitivity to glycopyrronium or other anticholinergics and should be used with caution in those with narrow-angle glaucoma, urinary retention, or other conditions that may be worsened by anticholinergic effects.

General data about AXHIDROX 2.2mg / dose

  • Substance: glycopyrronium bromide
  • Date of latest medicines list: 01-06-2023
  • Product code: W69551001
  • Concentration: 2.2mg / dose
  • Pharmaceutical form: cream
  • Quantity: 1
  • Product type: Original
  • Prescription status: P-RF - Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.

Marketing authorisation

  • Manufacturer: DR. AUGUST WOLFF GMBH & CO. KG ARZNEIMITTEL - GERMANIA
  • Holder: DR. AUGUST WOLFF GMBH & CO. KG ARZNEIMITTEL - GERMANIA
  • Number: 14974/2023/01
  • Shelf life: 3 years-after packing for marketing;dupa prima actionare-12 months

Pharmaceutical forms available for glycopyrronium bromide

Concentrations available for glycopyrronium bromide

  • 0.2mg/ml
  • 2.2mg/dose
  • 320mcg/ml
  • 44mcg